Alterity Therapeutics Limited Share Price Nasdaq
Stocks
ATHE
US02155X2053
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Nasdaq
01:30:00 19/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 3.910 USD | +4.27% |
|
-3.46% | +26.95% |
| 16/09 | Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target | MT |
| 31/08 | Alterity Therapeutics Enters Underwriting Agreement for Exercise of up to 8.4 Million Listed Options | MT |
| Market Cap | 7.06Cr 6.16Cr 5.81Cr 5.28Cr 9.89Cr 677.46Cr 9.93Cr 70Cr 27Cr 344.43Cr 27Cr 26Cr 1.11TCr | P/E 2027 * |
-3.29x | P/E 2028 * | -0.41x |
|---|---|---|---|---|---|
| Enterprise Value | 2.97Cr 2.59Cr 2.45Cr 2.22Cr 4.16Cr 284.98Cr 4.18Cr 29Cr 11Cr 144.89Cr 11Cr 11Cr 466.2Cr | EV / Sales 2027 * |
62.5x | EV / Sales 2028 * | 16.9x |
| Free-Float |
97% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATHE | Delayed | |
CBOE
| ATHE | Real-time | |
|
Deutsche Boerse AG
| PBN0 | Delayed | |
|
Börse Stuttgart
| PBN0 | Delayed |
Last Transcript: Alterity Therapeutics Limited
| 1 day | +4.27% | ||
| 1 week | -3.46% | ||
| Current month | -12.92% | ||
| 1 month | -12.13% | ||
| 3 months | -19.88% | ||
| 6 months | +18.84% | ||
| Current year | +26.95% |
| 1 week | 3.5 |  | 3.94 |
| 1 month | 3.5 | | 5.01 |
| Current year | 3.02 | | 5.89 |
| 1 year | 2.66 | | 5.89 |
| 3 years | 1 | | 7 |
| 5 years | 1 | | 13.8 |
| 10 years | 1 | | 51.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Stamler
CEO | Chief Executive Officer | 65 | 07/01/2021 |
| Director of Finance/CFO | - | 30/09/2024 | |
| Chief Tech/Sci/R&D Officer | - | 01/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Peter Marks
BRD | Director/Board Member | 70 | 29/07/2005 |
Lawrence Gozlan
BRD | Director/Board Member | 47 | 08/08/2011 |
David Stamler
BRD | Director/Board Member | 65 | 21/11/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.27% | -3.46% | - | - | 7.06Cr | |
| +0.62% | +2.58% | +1.33% | +28.55% | 4.63TCr | |
| -1.12% | +1.78% | +42.30% | +29.70% | 4.39TCr | |
| -3.04% | -6.29% | +338.56% | +542.28% | 4.09TCr | |
| -0.74% | +1.25% | +4.92% | +81.93% | 3.99TCr | |
| -0.50% | +0.67% | +10.29% | +41.57% | 2.95TCr | |
| -0.46% | +4.22% | +22.81% | +140.41% | 1.71TCr | |
| -0.97% | -10.17% | - | - | 1.55TCr | |
| +0.71% | +6.74% | +22.88% | +39.33% | 1.52TCr | |
| -3.14% | +31.91% | -11.79% | - | 1.4TCr | |
| Average | -0.43% | +3.76% | +53.91% | +129.11% | 2.92TCr | |
| Weighted average by Cap. | -0.93% | +1.87% | +68.25% | +138.81% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 5L 4L 4L 4L 7L 4.56Cr 7L 46.89L 18.09L 2.32Cr 17.86L 17.46L 7.46Cr | 19.78L 17.25L 16.29L 14.79L 27.71L 19Cr 27.83L 1.95Cr 75.3L 9.65Cr 74.32L 72.67L 31Cr |
| Net income | -2.75Cr -2.4Cr -2.27Cr -2.06Cr -3.86Cr -264.25Cr -3.87Cr -27Cr -10Cr -134.35Cr -10Cr -10Cr -432.28Cr | -3.08Cr -2.69Cr -2.54Cr -2.31Cr -4.32Cr -295.97Cr -4.34Cr -30Cr -12Cr -150.48Cr -12Cr -11Cr -484.17Cr |
| Net Debt | -4.09Cr -3.57Cr -3.37Cr -3.06Cr -5.73Cr -392.48Cr -5.75Cr -40Cr -16Cr -199.54Cr -15Cr -15Cr -642.04Cr | -3.72Cr -3.24Cr -3.06Cr -2.78Cr -5.2Cr -356.49Cr -5.23Cr -37Cr -14Cr -181.25Cr -14Cr -14Cr -583.18Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/26/18 | $3.910 | +4.27% | 3,088 |
| 17/26/17 | $3.750 | -2.60% | 10,667 |
| 16/26/16 | $3.850 | +10.00% | 10,510 |
| 15/26/15 | $3.500 | -9.33% | 14,571 |
| 14/26/14 | $3.860 | -4.69% | 32,999 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATH Stock
- ATHE Stock
Select your edition
All financial news and data tailored to specific country editions
